In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

A ground-breaking study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from the University of Virginia, Mount Sinai, the University of Michigan, the ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...

Prostate cancer is one of the most prevalent cancers among men, with the American Cancer Society estimating that ...

There is a limit of eight, 30-minute appointments. To schedule an appointment, or inquire further, call the hospital’s social ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Doctors recommend different treatments depending on the cancer case. From active surveillance to surgery and targeted ...

A team at the University of Cordoba and IMIBIC tests the protective effect of a fermented black garlic extract against ...

Under the new grant, Agarwal’s lab will work to not only confirm they have identified the correct compounds but to translate ...

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was ...